Palvella Therapeutics (PVLA) Non Operating Income (2016 - 2024)
Historic Non Operating Income for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $641000.0.
- Palvella Therapeutics' Non Operating Income rose 5117.92% to $641000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $685000.0, marking a year-over-year decrease of 379.21%. This contributed to the annual value of $511000.0 for FY2024, which is 2823.03% down from last year.
- As of Q4 2024, Palvella Therapeutics' Non Operating Income stood at $641000.0, which was up 5117.92% from -$20000.0 recorded in Q3 2024.
- Over the past 5 years, Palvella Therapeutics' Non Operating Income peaked at $884000.0 during Q1 2021, and registered a low of -$1.8 million during Q4 2020.
- For the 5-year period, Palvella Therapeutics' Non Operating Income averaged around $76210.5, with its median value being $229000.0 (2022).
- As far as peak fluctuations go, Palvella Therapeutics' Non Operating Income crashed by 233454.55% in 2020, and later surged by 157333.33% in 2021.
- Palvella Therapeutics' Non Operating Income (Quarter) stood at -$1.8 million in 2020, then skyrocketed by 120.62% to $378000.0 in 2021, then crashed by 185.98% to -$325000.0 in 2022, then soared by 230.46% to $424000.0 in 2023, then surged by 51.18% to $641000.0 in 2024.
- Its Non Operating Income stands at $641000.0 for Q4 2024, versus -$20000.0 for Q3 2024 and $64000.0 for Q2 2024.